Cargando…
New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony
Cutaneous leishmaniasis is a skin infection caused by the Leishmania species, an intracellular protozoan parasite that is transmitted by various species of female sandflies. According to the geographic distribution and vectors, leishmaniasis is classified as Old World or New World cutaneous leishman...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582933/ https://www.ncbi.nlm.nih.gov/pubmed/23467266 http://dx.doi.org/10.5021/ad.2013.25.1.80 |
_version_ | 1782260635046772736 |
---|---|
author | Shin, Ji Yeon Lee, Young Bok Cho, Baik Kee Park, Hyun Jeong |
author_facet | Shin, Ji Yeon Lee, Young Bok Cho, Baik Kee Park, Hyun Jeong |
author_sort | Shin, Ji Yeon |
collection | PubMed |
description | Cutaneous leishmaniasis is a skin infection caused by the Leishmania species, an intracellular protozoan parasite that is transmitted by various species of female sandflies. According to the geographic distribution and vectors, leishmaniasis is classified as Old World or New World cutaneous leishmaniasis. In Korea, 24 cases of Old World cutaneous leishmaniasis have been reported, but New World cutaneous leishmaniasis has not been reported as yet. A 37-year-old man presented with a 3-month history of a painful and erythematous nodule with two satellite papules on the left postauricular area and a papule on the left arm after traveling to the Amazon region in Brazil. After we performed skin biopsies of the lesions, diagnosis of cutaneous leishmaniasis was made by the histopathological findings. After intralesional injection of sodium stibogluconate (Pentostam®, GlaxoSmithKline) twice a week for 4 weeks, the lesions improved with scarring. Herein, we discuss this case of New World cutaneous leishmaniasis that was successfully treated with intralesional injection of sodium stibogluconate (Pentostam®) in Korea. |
format | Online Article Text |
id | pubmed-3582933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Korean Dermatological Association; The Korean Society for Investigative Dermatology |
record_format | MEDLINE/PubMed |
spelling | pubmed-35829332013-03-05 New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony Shin, Ji Yeon Lee, Young Bok Cho, Baik Kee Park, Hyun Jeong Ann Dermatol Case Report Cutaneous leishmaniasis is a skin infection caused by the Leishmania species, an intracellular protozoan parasite that is transmitted by various species of female sandflies. According to the geographic distribution and vectors, leishmaniasis is classified as Old World or New World cutaneous leishmaniasis. In Korea, 24 cases of Old World cutaneous leishmaniasis have been reported, but New World cutaneous leishmaniasis has not been reported as yet. A 37-year-old man presented with a 3-month history of a painful and erythematous nodule with two satellite papules on the left postauricular area and a papule on the left arm after traveling to the Amazon region in Brazil. After we performed skin biopsies of the lesions, diagnosis of cutaneous leishmaniasis was made by the histopathological findings. After intralesional injection of sodium stibogluconate (Pentostam®, GlaxoSmithKline) twice a week for 4 weeks, the lesions improved with scarring. Herein, we discuss this case of New World cutaneous leishmaniasis that was successfully treated with intralesional injection of sodium stibogluconate (Pentostam®) in Korea. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2013-02 2013-02-14 /pmc/articles/PMC3582933/ /pubmed/23467266 http://dx.doi.org/10.5021/ad.2013.25.1.80 Text en Copyright © 2013 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Shin, Ji Yeon Lee, Young Bok Cho, Baik Kee Park, Hyun Jeong New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony |
title | New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony |
title_full | New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony |
title_fullStr | New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony |
title_full_unstemmed | New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony |
title_short | New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony |
title_sort | new world cutaneous leishmaniasis treated with intralesional injection of pentavalent antimony |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582933/ https://www.ncbi.nlm.nih.gov/pubmed/23467266 http://dx.doi.org/10.5021/ad.2013.25.1.80 |
work_keys_str_mv | AT shinjiyeon newworldcutaneousleishmaniasistreatedwithintralesionalinjectionofpentavalentantimony AT leeyoungbok newworldcutaneousleishmaniasistreatedwithintralesionalinjectionofpentavalentantimony AT chobaikkee newworldcutaneousleishmaniasistreatedwithintralesionalinjectionofpentavalentantimony AT parkhyunjeong newworldcutaneousleishmaniasistreatedwithintralesionalinjectionofpentavalentantimony |